It is a packaging private limited company based in Jammu, Jammu & Kashmir, India, established in 2021.
2021 | Jammu, Jammu & Kashmir, India | ActiveAeren Pharma Foils Private Limited, a active private limited company, was established on 11 August 2021 in Jammu, Jammu & Kashmir, India. Engaging in packaging films & foils within the manufacturing sector, it holds CIN: U28999JK2021PTC012613. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Goldie Agarwal (Director), Dhruv Aggarwal (Additional Director), Kriti Aggarwal (Additional Director). It holds ₹102.93 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 28 A/B Gandhi Nagar, Jammu, Jammu & Kashmir, 180004.
U28999JK2021PTC012613
012613
11 August 2021
₹1.50 M
₹0.10 M
Roc Jammu
Unlisted
Active
Explore comprehensive insights into Aeren Pharma Foils Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Goldie Agarwal | Director | 11 Aug 2021 | Current |
| Dhruv Aggarwal | Additional Director | 15 Jul 2024 | Current |
| Kriti Aggarwal | Additional Director | 15 Jul 2024 | Current |
| Amrish Aggarwal | Director | 11 Aug 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aeren Pharma Foils Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Aeren Pharma Foils's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,029,340,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2025 | Others | ₹5.00 Cr | Open |
| 27 May 2024 | Standard Chartered Bank | ₹1.26 Cr | Open |
| 27 May 2024 | Standard Chartered Bank | ₹16.00 Cr | Open |
| 14 Jun 2023 | Others | ₹22.40 Cr | Open |
| 23 May 2023 | Others | ₹15.50 Cr | Open |
Explore comprehensive loan charge details -
Aeren Pharma Foils has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aeren Pharma Foils, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aeren Pharma Foils's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 50.00 M with Charge ID 101101733 was registered on 07 Apr 2025. was documented.
A charge with Standard Chartered Bank of Rs. 160.00 M registered on 27 May 2024 with Charge ID 100927419 was modified on 21 Feb 2025. was recorded as a recent event.
Progress on Aeren Pharma Foils Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Dhruv Aggarwal was appointed as a Additional Director was appointed as a Additional Director on 15 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Kriti Aggarwal was appointed as a Additional Director was appointed as a Additional Director on 15 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Progress on A charge with Standard Chartered Bank amounted to Rs. 12.59 M with Charge ID 100927424 was registered on 27 May 2024. was documented.
The CIN of Aeren Pharma Foils Private Limited is U28999JK2021PTC012613.
Aeren Pharma Foils Private Limited is headquartered at 28 A/B Gandhi Nagar, Jammu, Jammu & Kashmir, 180004.
Aeren Pharma Foils Private Limited was incorporated on 11 August 2021.
The current directors of Aeren Pharma Foils Private Limited are
The primary industry of Aeren Pharma Foils Private Limited is Manufacturing.
Aeren Pharma Foils Private Limited is unlisted.
The authorized capital of Aeren Pharma Foils Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX